Wednesday, September 22, 2021 8:17:41 AM
rollup, Ok. Sounds good. Then how does that:
1) impact the RLFTF O/S and float values?
2) impact on the 'price' per share?
3) impact the EPS calculation (earnings per share)?
One of the advantages of an R/S is the O/S drops, which results in a smaller denominator in the calc, which results in a higher and better looking EPS metric.
Thanks
1) impact the RLFTF O/S and float values?
2) impact on the 'price' per share?
3) impact the EPS calculation (earnings per share)?
One of the advantages of an R/S is the O/S drops, which results in a smaller denominator in the calc, which results in a higher and better looking EPS metric.
Thanks
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
